We had the pleasure of meeting with Yona Levites (Center for Translational Research in Neurodegenerative Disease, University of Florida, Gainesville, FL, USA ) to discuss her phase 1 study investigating the scFv-CD protein as a framework for identifying an optimized immunotherapy for Alzheimer’s Disease, and potentially other neurodegenerative disorders.
Part 1 of the discussion can be viewed here.
The abstract entitled ‘Immunotherapeutic approaches in Alzheimer’s Disease’ was presented at The 15th International Conference for Alzheimer’s & Parkinson’s Diseases (Virtual), March 8-14, 2021.
- Could you give us a brief description of the scFv-CD protein you have developed? (0:20)
- What have you learned from preclinical studies of the scFv-CD protein? (2:06)
Disclosures: Yona Levites has nothing to disclose in relation to this video.
Support: Interview and filming supported by Touch Medical Media.
Filmed as a highlight of AD/PD Virtual 2021.
Share this Video
Related Videos In Alzheimer's Disease & Dementia
Kristian Steen Frederiksen, EAN 2023: The new EAN guidelines
Dr Kristian Steen Frederiksen (Danish Dementia Research Center, Denmark, Copenhagen) summarizes some of the key updates to the EAN guidelines, and the take-home messages presented at the annual European Academy of Neurology (EAN), July 1–4, 2023. Disclosures: Kristian Steen Frederiksen has no financial or non-financial conflicts of interest to declare in relation to this video. Support: Interview and filming was supported by Touch […]
Kristian Steen Frederiksen, EAN 2023: Highlights in Alzheimer’s disease and dementia
Dr Kristian Steen Frederiksen (Danish Dementia Research Center, Denmark, Copenhagen) discusses his highlights from the annual European Academy of Neurology (EAN), July 1–4, 2023 in the field of Alzheimer’s disease and dementia. Disclosures:Kristian Steen Frederiksen has no financial or non-financial conflicts of interest to declare in relation to this video. Support: Interview and filming was supported by Touch Medical Media. The interview was conducted by Sophie Nickelson. […]
Kristen George, AAIC 2022: Experiences of discrimination on cognitive function and ageing among the oldest old: The LifeAfter90 (LA90) Study
The LifeAfter90 (LA90) Study aims to understand what cognitive ageing and dementia look like among individuals aged 90 and above. In this interview, Dr Kristen George (University of California Davis School of Medicine, University of California, Davis, CA, USA) discussed what the study found in terms of the effect of discrimination on the cognitive function of this […]
Journal articles and more to your inbox
Get the latest clinical insights from touchNEUROLOGYSign me up!